ERA-NET Patho Geno Mics m pat w

ERA-NET Patho. Geno. Mics m . pat w o gen ho ww M. Karrasch, FZJ 23. 05. 2005 . net a s-er ic

ERA-NET Patho. Geno. Mics 1. 2. Structure of the ERA-NET Patho. Geno. Mics / Boards, Work programme and activities 3. Transnational Research Activities 4. M. Karrasch, FZJ 23. 05. 2005 What is an ERA-NET? The today‘s subject: Strategic Research Agenda

ERA-NET Patho. Geno. Mics ERA-NET Schema ERA-NET: new instrument within the FP 6 Objective: “Strengthening the European Research Area“ (ERA) Objective: enhance the cooperation and coordination of national research activities - through networking of national/regional programmes including their mutual opening and the development and implementation of joint research activities M. Karrasch, FZJ 23. 05. 2005

ERA-NET Patho. Geno. Mics ERA-NET Scheme Eligible Partners: Partners are programme owners/managers acting on behalf of ut national/regional public authorities : ng, b sting di i h fun of ex arc n se inatio ect re oorcouncils such as ministries, funding agencies, research d dir c lude inc ental ot nm oes n tergover d s. -NET s for in mme ERA e ur gra meas nding pro all fu r new o M. Karrasch, FZJ 23. 05. 2005

ERA-NET Patho. Geno. Mics 1. 2. Structure of the ERA-NET Patho. Geno. Mics / Boards, Work programme and activities 3. Transnational Research Activities 4. M. Karrasch, FZJ 23. 05. 2005 What is an ERA-NET? The today‘s subject: Strategic Research Agenda

ERA-NET Patho. Geno. Mics Boards Network Steering Committee NSC Funding Organisations External Advisory Board EAB Scientists Coordinator Joint Secretariat Administration Executing Board EB Programme/Project Management M. Karrasch, FZJ 23. 05. 2005 Affiliated Partners Funding Organisations European Commission

ERA-NET Patho. Geno. Mics ERA-NET Schema Activities: 1. Systematic exchange of information & “best practices” 2. Common strategies 3. Development of common activities 4. Implementation of transnational research activities M. Karrasch, FZJ 23. 05. 2005

ERA-NET Patho. Geno. Mics 9/2005 4/2005 WP 1 + 2 information exchange about the national programmes Commitment of the partners regarding joint call 01/2006 WP 7 Development of a legal, contractual and financial Framework and application/ evaluation system Agreement Framework and application/ evaluation system WP 3 development of a „European Research Agenda“ Agreement on „European Research Agenda“ WP 8 first Joint call WP 6 Partne-ring Event Development of transnational research consortia WP 4 SMEs/industry working group, PIPs network (Patho. Geno. Mics innovation partners) WP 6 Working group on training issues WP 9 Science and Society: IT-based communication platforms for M. Karrasch, FZJ 23. 05. 2005 the public, Printed information material, On-spot-presentations

ERA-NET Patho. Geno. Mics 10/2004 Start 9/2005 4/2005 2004 WP 1 + 2 information exchange about the national programmes Commitment of the partners regarding joint call M. Karrasch, FZJ 23. 05. 2005 12/2005 WP 7 development of the admin. framework + Application/ evaluation system 2006 Agreement about admin. framework and appl. / eval. system Agreement WP 3 development about SRA of a „strategic Work programme Research Agenda“ WP 8 1 st joint call 2007 WP 8 2 nd joint call WP 8 Project execution Partnemilestones Call text and IPR guideline: Austria, Finland, ring deliverables Event 1 sttransnational draft 04/05 France, Germany, WP 6 development of 2 nd and 3 rd research concortia Spain draft 05/05 Slovenia, Strategic Research Agenda: final group 08/05 maybe: Portugal, versiondraft 06/05 WP 4 SMEs/industry working. Sweden 1 st final WP 6 working group „training issues“ version 09/05 WP 9 Wissenschaft und Gesellschaft: Kommunikationsplattform

ERA-NET Patho. Geno. Mics Public accessible database, contains information about and allows searches for: - Research groups in the Pathogenomics field topics of current research projects Studied microorganisms -> Will probably be available in 4 weeks please supplement these information with e. g. summaries of your own research topics, link to your web page… WP 9 Science and Society: IT-based communication platforms for M. Karrasch, FZJ 23. 05. 2005 the public, Printed information material, On-spot-presentations

ERA-NET Patho. Geno. Mics 1. 2. Structure of the ERA-NET Patho. Geno. Mics / Boards, Work programme and activities 3. Transnational Research Activities 4. M. Karrasch, FZJ 23. 05. 2005 What is an ERA-NET? The today‘s subject: Strategic Research Agenda

ERA-NET Patho. Geno. Mics Transnational Research Activities: - „nationality principle“ (each country shall fund ist own research entities) - countries participating in the first joint call: Austria, Finland, Germany, Slovenia, Spain maybe also participating: France, Israel, Latvia, Portugal, Sweden - research groups from other countries may also participate, provided they have their own funding M. Karrasch, FZJ 23. 05. 2005

ERA-NET Patho. Geno. Mics Transnational Research Activities: - who may submit proposals? Research groups, organised in transnational consortia, will submit a consorted proposal - which topics will be funded? Topics covering Genome Research on pathogenic Microorganisms (details will be given in the call for proposals, approx. Jan. 2006) - will there be further regulations? yes, e. g. transnational research consortia, consorted proposals variable geometrie; details are still to be defined further regulations will be published in the call text M. Karrasch, FZJ 23. 05. 2005

ERA-NET Patho. Geno. Mics 1. 2. Structure of the ERA-NET Patho. Geno. Mics / Boards, Work programme and activities 3. Transnational Research Activities 4. M. Karrasch, FZJ 23. 05. 2005 What is an ERA-NET? The today‘s subject: Strategic Research Agenda for Patho. Geno. Mics

ERA-NET Patho. Geno. Mics Time schedule: Strategic Research Agenda (SRA) Paris 23. -25. 05 06/2005 07/2005 Helsinki 26. -27. 09. 05 2005 Expert Meeting: indepth discussion about SRA, development of a first draft SRA by Rapporteurs M. Karrasch, FZJ 23. 05. 2005 Publication of the SRA draft in FEMS letters (and other journals) Scientific feedback Agreement on SRA

ERA-NET Patho. Geno. Mics M. Karrasch, FZJ 23. 05. 2005

ERA-NET Patho. Geno. Mics Workpackage 3: Strategic Research Agenda (SRA) Why a Strategic Research Agenda for Patho. Geno. Mics? To define the most important topics for future Patho. Geno. Mics research To outline the importance of this topic -> basis for discussions with - M. Karrasch, FZJ 23. 05. 2005 national funding authorities (e. g. development of new programmes) European Commission other stakeholders

ERA-NET Patho. Geno. Mics Pathogenomics: A Proposed European Research Agenda A: The microbes B: Host-microbe interactions C: Development and improvement of tools D. Integration at a European Level M. Karrasch, FZJ 23. 05. 2005

ERA-NET Patho. Geno. Mics Workpackage 3: Strategic Research Agenda (SRA) T 3. 2 Indepth discussion with high-level experts, 23 rd – 25 th May 2005, Paris Based on first ideas to structure a European Research Agenda developed on a 1 st preparatory meeting (June 2003, Würzburg) 3. 2(a) 3. 2(b) M. Karrasch, FZJ 23. 05. 2005 Civil Aspects of pathogenomics Impact of pathogenomics on biosecurity and safety research

ERA-NET Patho. Geno. Mics Workpackage 3: Strategic Research Agenda (SRA) T 3. 3 Feedback from the scientific community § “Rapporteurs“ will summarise the indepths expert discussion and continue drafting the agenda (up to 20 pages) § Draft Research Agenda will be published in FEMS Letters in order to create a scientific „feedback loop“ (deadline approx. 2 months) àfinal version of the „European Pathogenomics Research Agenda“in September 2005 M. Karrasch, FZJ 23. 05. 2005

ERA-NET Patho. Geno. Mics Partner Country Participation in the first call to be published in January 2006 Participation in the second call to be published in January 2007 Austria (bm: bwk) Yes Finland Yes France maybe Yes Israel maybe Latvia maybe Portugal maybe Slovenia Yes Spain Yes Austria (FWF) No No Lithuania Yes Malta Yes Netherlands No No maybe No No Germany Hungary Affiliated Partners Norway Sweden UK (BBSRC) M. Karrasch, FZJ 23. 05. 2005 UK (WT)

Partner Country Name External Advisory Board ERA-NET Patho. Geno. Mics Institute/ Company 1 + 2, Germany Prof. Dr. Matthias Frosch Institut für Hygiene und Mikrobiologie, University of Wuerzburg Prof. Dr. Klaus-Peter Koller Aventis Deutschland Gmb. H, Frankfurt 3, Austria Prof. Dr. Heinz Redl LBI für exp. und klin. Traumatologie, Unfallkrankenh. L. Böhler, Wien Prof. Dr. Michael Wagner Abt. Mikrobielle Ökologie, Institut für Ökologie, Universität Wien Prof. Timo Korhonen University of Helsinki Prof. Mikael Skurnik University of Helsinki Prof. Dr. Michele Mock Institute Pasteur, Paris Prof. Dr. Christophe d'Enfert Unité Biologie et Pathogenicite Fongiques, Institute Pasteur, Paris Prof. Dr. Andrée Lazdunski IBSM / CNRS Marseille Prof. Dr. Béla Nagy Vet. Med. Research Inst. of the Hung. Academy of Sciences, Budapest Prof. Dr. Levente Emody University of Pécs, Faculty of Medicine 7, Israel Prof. Dr. Eliora Z. Ron Faculty of Life Sciences, Tel-Aviv University 8, Latvia Prof. Pauls Pumpens University of Latvia, Biological Faculty Prof. Vaija Zilevica University of Latvia, Medical Faculty 10, Slovenia Prof. Dr. Peter Raspor Chair for Biotechnology, Biotechnical Faculty, University of Ljubljana Asst. prof. Dr. Roman Jerala Laboratory of Biotechnology, National Institute of Chemistry, Ljubljana 11, Spain Prof. Dr. Francisco García-del Portillo Centro Nacional de Biotechnología, Campus de Cantoblanco, Madrid 4, Finland 5, France 6, Hungary 9, Portugal M. Karrasch, FZJ Prof. 23. 05. 2005 Dr. Carlos Martin University of Zaragoza

ERA-NET Patho. Geno. Mics M. Karrasch, FZJ 23. 05. 2005